about
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptideAlzheimer's disease amyloid-beta links lens and brain pathology in Down syndromeIron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's diseaseA spectrophotometric assay for 6-phosphogluconolactonase involving the use of immobilized enzymes to prepare the labile 6-phosphoglucono-delta-lactone substrateNon-conjugated small molecule FRET for differentiating monomers from higher molecular weight amyloid beta speciesCharacterization of a Drosophila Alzheimer's disease model: pharmacological rescue of cognitive defectsSynaptic abnormalities in a Drosophila model of Alzheimer's diseaseCytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.Metal exposure and Alzheimer's pathogenesis.Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's diseaseAnesthetic propofol attenuates the isoflurane-induced caspase-3 activation and Aβ oligomerization.Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation.Redox-active metals, oxidative stress, and Alzheimer's disease pathology.Clearance of Alzheimer's Abeta peptide: the many roads to perdition.Role of common and rare APP DNA sequence variants in Alzheimer diseaseNear-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditionsReduced amyloidogenic processing of the amyloid beta-protein precursor by the small-molecule Differentiation Inducing Factor-1The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivoThe common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels.Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.Hypocapnia induces caspase-3 activation and increases Abeta production.Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.Alzheimer's disease: the potential therapeutic role of the natural antibiotic amyloid-β peptideThe gene defects responsible for familial Alzheimer's disease.Association of membrane-bound amyloid precursor protein APP with the apolipoprotein E receptor LRP.Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).An abnormality of plasma amyloid protein precursor in Alzheimer's disease.Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease.Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia.Human brain beta A4 amyloid protein precursor of Alzheimer's disease: purification and partial characterization.The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth.Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors.A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease.Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients.
P50
Q21090025-1B6AF3EA-3853-49B6-991B-7062E4CB0E92Q21136371-B08CDB4D-EFCE-4676-A7C4-3421086DE0E9Q24298553-1FA707EA-C85B-49BC-AD5E-DD01E259FB84Q28361234-5CAC6628-DDEE-4EA5-AAAD-B66D27D02867Q28478000-7356D71F-D814-44BE-8B64-0C58934C448EQ28478463-F8A40696-2194-4E7E-BF73-2AF0E461501CQ30573528-F1525DF8-B364-4B5B-9C61-1F5DC6926DA0Q30725675-3EBAF965-5775-450D-A927-048353D1CB86Q33234815-67F23442-E6E7-4E39-A2EA-5CCB98D3269FQ33894236-88434C06-68B1-44B8-BC4E-0A2C47FFE444Q34070553-0C7637A5-9B01-488D-9DD6-50853A7B5924Q34082498-FD6EBCA7-5485-47AF-96DD-1B90200D9096Q34372665-216AB1BD-2D97-4C9C-8138-2873ECC390F6Q34575058-1630DDA9-FCF0-4F81-8168-96C28AE84822Q35754493-2FEDFEED-4310-418D-918B-613EAFA8DC72Q35875785-DCE4DCA5-19AF-4ECC-A4DD-8890B21AFD4DQ35883202-EB287513-662F-4D35-A31D-0D8DFBE04117Q35946092-8EC9910A-5991-433C-A507-19F6C70BE92AQ36585560-CF2DC9CB-7A8A-49C5-A250-0A452921BE79Q36982117-9515B1B4-9C2E-4B33-A36C-9B6312C9B6C6Q37032670-64B54811-0974-4A23-AAFF-C39E69C11BD1Q37357592-0D6901C4-7DDA-4145-B36D-C541DE572743Q37357625-9AD7DE0C-99E1-4FD4-9385-9532809186B9Q40243733-288C016F-40E9-479F-B0B4-2041EC56F96EQ40484248-C7A39162-59C1-45EC-A297-E15E422F74BBQ40550334-7E230C30-D674-4EDE-ADF1-A249A2A7394DQ41288332-883FBBE1-7390-4A48-9496-6FAB762AF181Q43540734-72A026BD-9373-4CC3-90DC-027E95C9040CQ44111677-7A8FBC49-F537-4C21-AE92-C479F588EEF6Q44552208-18D3C467-20A1-4EEF-A5BF-3EF1A301A4D5Q44724513-567CB5C3-A8BF-4167-BA7D-DB5E2C0C1DA5Q44728792-8601E758-F684-4FAE-B1F7-D3A0F8DBEDBEQ46678415-7890F093-CE47-46A7-81C1-0E18170DB73FQ48426015-9F4CE9C3-E3AF-4BA7-8759-EC87298A007EQ48458288-B7443BD4-F940-4B02-9EB7-89B06CEB6EA0Q48499472-15947B8F-342E-48D8-8877-62D3171EBB41Q48502637-DA520C29-52FC-450E-8045-4C06CA599F39Q48617420-85C72DE9-EBBF-478A-9BD8-01565A439E2DQ48625478-32DB45D6-2D16-4A6E-B157-9D31E353480AQ49023772-6227EBBE-CF5F-4BF7-AC3D-3AAE55A3D08F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Robert D. Moir
@ast
Robert D. Moir
@da
Robert D. Moir
@de
Robert D. Moir
@en
Robert D. Moir
@es
Robert D. Moir
@fo
Robert D. Moir
@fr
Robert D. Moir
@is
Robert D. Moir
@kl
Robert D. Moir
@nb
type
label
Robert D. Moir
@ast
Robert D. Moir
@da
Robert D. Moir
@de
Robert D. Moir
@en
Robert D. Moir
@es
Robert D. Moir
@fo
Robert D. Moir
@fr
Robert D. Moir
@is
Robert D. Moir
@kl
Robert D. Moir
@nb
altLabel
Robert D Moir
@da
Robert D Moir
@de
Robert D Moir
@en
prefLabel
Robert D. Moir
@ast
Robert D. Moir
@da
Robert D. Moir
@de
Robert D. Moir
@en
Robert D. Moir
@es
Robert D. Moir
@fo
Robert D. Moir
@fr
Robert D. Moir
@is
Robert D. Moir
@kl
Robert D. Moir
@nb
P1053
M-7612-2017
P106
P21
P31
P3829
P496
0000-0001-5431-3553